LORATI Successfully Develops Effective Treatment for Cataract, Glaucoma, and Macular Degeneration Using Eye Drops

    TAIPEI TAIWAN, May 04, 2017 /24-7PressRelease/ -- Lorati Company Limited, a Taiwan-based biotechnology and pharmaceutical company, today announced that it has successfully developed nano-grade eye drops, which can effectively treat and reverse cataract, glaucoma, and macular degeneration.

Lorati CEO, David Lo, said nano-grade eye drops, based on montmorillonite, also known as God's clay, is believed to be the last-ditch treatment for cataract, glaucoma, and macular degeneration. Huge improvement can be seen within one month of treatment by nano-grade eye drops. After being treated for a couple of months, patients with these chronic eye diseases have gradually restored their vision.

Mr. Lo explained, "Optic nerves, which transmit visual information from retina to the brain, can be regenerated using Lorati's eye drops. This is the first time in human history. Only real stem cell therapy can achieve the regeneration of optic nerves."

Mr. Tony Hester, a 45-year-old Caucasian American living in Florida, developed glaucoma about 5 years ago. His right eye was considered legally blind; he could not see people standing in front of him. After using the eye drops for two months, he sees eyesight improvement in his right eye. "This is the proof of optic nerves having been regenerated," said Mr. Lo. (A complete statement from Mr. Tony Hester can be found on the company's website, www.godforeye.com)

"No existing eye drops or drugs on the market can reverse these three eye diseases. Neither can any surgery. Patients cannot do much but slowly lose their eyesight and eventually end up legally blind. With the introduction of nano-grade eye drops, we hope to help more people regain their eyesight," said Mr. Lo.

For more information, please visit Lorati's website at www.godforeye.com

ALL GLORY BELONGS TO GOD!

Contact:
Lorati Co., Ltd.
Tel: +886 4 2483 5965
Email: [email protected]

# # #